Comparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiency
Makaleler > Tam Makale · 2021
Yazarlar: AHMET DAYLAN, Fatih İSLAMOĞLU
Journal of Vascular Surgery: Venous and Lymphatic Disorders, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2021, cilt 10, ss 661-668.e2
DOI: 10.1016/j.jvsv.2021.09.001
Özet
<p><span style="color: rgb(0, 0, 0);">Background: Varicose vein treatment has shifted to less invasive techniques owing to the complications associated with</span></p><p><span style="color: rgb(0, 0, 0);">traditional treatment. The present study was designed to compare the effectiveness of cyanoacrylate ablation (CAA) with</span></p><p><span style="color: rgb(0, 0, 0);">radiofrequency ablation (RFA).</span></p><p><span style="color: rgb(0, 0, 0);">Methods: Patients who had undergone RFA vs CAA (634 vs 246 patients) to treat great saphenous vein (GSV)</span></p><p><span style="color: rgb(0, 0, 0);">insuf ciency during a 5-year period were included in the present study. The preoperative and postoperative CEAP</span></p><p><span style="color: rgb(0, 0, 0);">(clinical, etiologic, anatomic, pathophysiologic) class, symptoms, recurrence, and Doppler ultrasound ndings were</span></p><p><span style="color: rgb(0, 0, 0);">compared.</span></p><p><span style="color: rgb(0, 0, 0);">Results: All the veins in both groups were occluded at day 5. The 1-month closure rates were 97.3% and 98.7% for RFA and</span></p><p><span style="color: rgb(0, 0, 0);">CAA, respectively. The overall postoperative closure rates at 5 years were 93.1% and 91.1% for RFA and CAA, respectively.</span></p><p><span style="color: rgb(0, 0, 0);">The postoperative symptoms, CEAP class, and Doppler ultrasound ndings were similar in both groups. The 5-year</span></p><p><span style="color: rgb(0, 0, 0);">symptom-free survival rates were 73.5% and 72.0% in the RFA and CAA groups, respectively. The venous clinical</span></p><p><span style="color: rgb(0, 0, 0);">severity scores had decreased from 5.9 6 1.2 to 0.9 6 0.8 and 5.8 6 0.9 to 0.8 6 0.6 in the RFA and CAA groups,</span></p><p><span style="color: rgb(0, 0, 0);">respectively. The Aberdeen varicose vein questionnaire scores had decreased from 19.7 6 5.5 to 4.8 6 1.5 in the RFA group</span></p><p><span style="color: rgb(0, 0, 0);">and from 18.9 6 5.8 to 4.9 6 1.4 in the CAA group.</span></p><p><span style="color: rgb(0, 0, 0);">Conclusions: CAA seems to be the ideal treatment for GSV insuf ciency because it is suitable for most patients and</span></p><p><span style="color: rgb(0, 0, 0);">is nonthermal and nontumescent, with satisfactory results comparable to those with RFA. Long-term outcomes and</span></p><p><span style="color: rgb(0, 0, 0);">cost analyses from larger series are required to con rm our ndings. (J Vasc Surg Venous Lymphat Disord</span></p><p><span style="color: rgb(0, 0, 0);">2022;10:661-8.)</span></p><p><span style="color: rgb(0, 0, 0);">Keywords: Chronic venous insuf ciency; Cyanoacrylate ablation; Radiofrequency ablation; Varicose veins</span></p><p><br></p>